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SUMMARY
MicroRNAs (miRNAs) inhibit mRNA expression in general by base pairing to the 3′UTR of target
mRNAs and consequently inhibiting translation and/or initiating poly(A) tail deadenylation and
mRNA destabilization. Here we examine the mechanism and kinetics of miRNA-mediated
deadenylation in mouse Krebs-2 ascites extract. We demonstrate that miRNA-mediated mRNA
deadenylation occurs subsequent to initial translational inhibition, indicating a two-step mechanism
of miRNA action, which serves to consolidate repression. We show that a let-7 miRNA-loaded RNA-
induced silencing complex (miRISC) interacts with the poly(A)-binding protein (PABP) and the
CAF1 and CCR4 deadenylases. In addition, we demonstrate that miRNA-mediated deadenylation is
dependent upon CAF1 activity and PABP, which serves as a bona fide miRNA coactivator.
Importantly, we present evidence that GW182, a core component of the miRISC, directly interacts
with PABP via its C-terminal region and that this interaction is required for miRNA-mediated
deadenylation.
INTRODUCTION
MicroRNAs (miRNAs) are short single-stranded RNAs (~21 nt in length) encoded within the
genome of species ranging from protozoans to plants to mammals (Bartel, 2004; Molnar et al.,
2007). miRNAs play key roles in a broad range of biological processes including
hematopoiesis, insulin secretion, apoptosis, and organogenesis (Bartel, 2004). When
assembled together with Argonaute (Ago) proteins into the miRNA-induced silencing complex
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(miRISC), miRNAs base pair with and repress mRNA expression through mechanisms that
are not fully understood (Eulalio et al., 2008a; Filipowicz et al., 2008).
miRNAs were reported to employ different mechanisms to inhibit expression of targeted
mRNAs (Eulalio et al., 2008a; Filipowicz et al., 2008). Some data indicate that miRNAs
interfere with mRNA translation at the initiation step (Chendrimada et al., 2007; Ding and
Grosshans, 2009; Humphreys et al., 2005; Mathonnet et al., 2007; Pillai et al., 2005; Thermann
and Hentze, 2007; Wang et al., 2008), whereas other studies concluded that the miRNA
machinery represses translation at postinitiation steps (Gu et al., 2009; Lytle et al., 2007;
Maroney et al., 2006; Nottrott et al., 2006; Olsen and Ambros, 1999; Petersen et al., 2006).
miRNAs have been observed, although not in every study, to mediate deadenylation and/or
decay of targeted mRNAs (Behm-Ansmant et al., 2006; Giraldez et al., 2006; Wakiyama et
al., 2007; Wu et al., 2006).
In addition to Ago proteins, GW182 proteins also play key roles in miRNA-mediated
repression. One GW182 protein (Gawky) exists in Drosophila, and three GW182 paralogs
(TNRC6A, TNRC6B, and TNRC6C) are present in mammals. Direct interaction of GW182
with Ago proteins is critical for miRNA-mediated translation repression and mRNA decay
(Eulalio et al., 2008b). Studies conducted with either TNRC6C or Gawky artificially tethered
to a reporter mRNA demonstrated that a region within their C termini is required for repression
of translation (Chekulaeva et al., 2009; Eulalio et al., 2009b; Zipprich et al., 2009).
Cell culture-based assays invariably measure miRNA effects hours or days after the initial
mRNA target site recognition, making it difficult to ascertain the temporal order and
contribution of the different proposed mechanisms to mRNA repression. Moreover, RNAi-
based approaches for identifying miRNA-associated factors may perturb cellular
transcriptional programs in such a way that it becomes difficult to determine direct
contributions. Thus, developing an in vitro system that faithfully recapitulates all aspects of
miRNA-mediated repression is necessary to elucidate the biochemistry of miRNA mechanisms
of action, especially at early time points. Such systems have recently been reported (Mathonnet
et al., 2007; Thermann and Hentze, 2007; Wakiyama et al., 2007; Wang et al., 2006).
To explore the mechanisms that miRNAs utilize to repress mRNA expression in mammals,
we utilized an in vitro translation extract from mouse Krebs-2 ascites cells (referred to
throughout as Krebs extract). We showed before that the earliest detectable effect of miRNA
action is the inhibition of cap-dependent translation initiation (Mathonnet et al., 2007). We
demonstrate here that miRNA-mediated deadenylation follows the initial inhibition of cap-
dependent translation. We further show that Ago2 interacts with the CNOT7/CAF1 (hereafter
referred to as CAF1) deadenylase and poly(A)-binding protein (PABP) in an RNA-independent
manner, and that both proteins are required to facilitate miRNA-mediated deadenylation.
Importantly, we show that PABP physically interacts with the miRISC by directly binding the
C terminus of GW182 and is required for deadenylation.
RESULTS
miRNA-Mediated Deadenylation Follows Initial Translation Inhibition
We previously described an in vitro translation extract derived from Krebs-2 ascites cells that
contains high levels (~150 pM) of the let-7a (referred throughout as let-7) miRNA and displays
a faithful let-7 miRNA response (Mathonnet et al., 2007). The Krebs extract manifests reduced
translation initiation of in vitro-transcribed let-7-targeted mRNAs starting within the first 15
min of incubation without detectable mRNA degradation (Mathonnet et al., 2007). Since
miRNAs were also reported to induce mRNA deadenylation (Eulalio et al., 2009a; Giraldez et
al., 2006; Wakiyama et al., 2007; Wu et al., 2006), and since deadenylation generally results
Fabian et al. Page 2
Mol Cell. Author manuscript; available in PMC 2010 January 7.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
in translational repression (Wormington, 1993), we wished to determine whether miRNA-
mediated deadenylation can be recapitulated in a Krebs extract and study the temporal
relationship between translation inhibition and deadenylation. A polyadenylated RL-6xB
mRNA (Figure 1A), labeled uniformly with 32P-UTP, was incubated in a Krebs extract, and
its integrity was analyzed by denaturing polyacryl-amide-gel electrophoresis (PAGE) followed
by autoradiography. A new RNA band migrating faster than the full-length mRNA was
detected after ~1 hr of incubation (Figure 1B, lanes 3–7, and see Figure S1 available online).
Formation of the new RNA species was dependent on let-7 miRNA as (1) inclusion of anti-
let-7 2′-O-methylated oligonucleotide (2′-O-Me), but not anti-miR122 2′-O-Me, in the Krebs
extract blocked the generation of this product (lanes 8 and 9, respectively); and (2) a reporter
containing mutations in nucleotides complementary to the let-7 “seed” sequence (RL-6xBMut-
pA; see Figure 1A and Figure 1B, lanes 1–7), and a reporter devoid of let-7 sites (RL-pA;
Figure S1) failed to give rise to this band. Cloning and sequencing of the new RNA species
using an oligonucleotide-ligation RT-PCR strategy (Figure S2) demonstrated that it represents
a deadenylation product of the RL-6xB-pA mRNA. Thus, let-7 miRNA mediates deadenylation
of the targeted mRNA in the Krebs extract, but with the earliest detection only after 1.3 hr of
incubation. As translational inhibition (~55%) occurs within the first hour of incubation in the
same Krebs extract in which deadenylation has been monitored (Figure 1C; see also Mathonnet
et al. [2007]), it appears that miRNA-mediated inhibition of cap-dependent translation precedes
mRNA deadenylation. When translation of RL-6xB-pA mRNA was allowed to proceed for
longer times, the degree of translation repression increased from ~55% at 1 hr to ~77% at 2 hr
(Figure 1C; three different experiments). These data indicate that deadenylation may
consolidate the initial inhibition of cap-dependent translation.
Next, we asked whether deadenylation is dependent on translation. To this end, translation was
inhibited in the Krebs extract by the addition of either cycloheximide (Figure 1B, lanes 10–
12), which blocks translation elongation, or hippuristanol (lanes 13–15), which inhibits
translation initiation (Bordeleau et al., 2006). Inhibiting either step of translation failed to block
let-7-induced deadenylation of RL-6xB-pA mRNA. We then examined whether the m7GpppG-
cap structure is required for miRNA-mediated deadenylation. Deadenylation assays were
conducted with RL-6xB-pA and RL-6xBMUT-pA mRNAs possessing an ApppG-cap, which
cannot be bound by eIF4E but protects the RNA against degradation by 5′-3′ exonucleases.
Neither the time course nor the extent of deadenylation of A-capped RL-6xB-pA significantly
differed from RL-6xB-pA bearing an m7GpppG structure (Figure 1B). Since miRNA-mediated
deadenylation is an m7GpppG-cap- and translation-independent event, we examined whether
any RNA element upstream of the RL-6xB-pA 3′UTR is required for miRNA-mediated
deadenylation. ApppG-capped 3′UTR transcripts were generated that lack an open reading
frame and contain six either functional (6xB-3′UTR) or mutated (6xBMUT-3′UTR) let-7 sites
and a 98 nt poly(A) tail (Figure 1D). The 6xB-3′UTR RNA recapitulated both the time course
and the deadenylation pattern observed for the full-length RL-6xB-pA mRNA (Figure 1D).
Deadenylation was dependent on let-7 miRNA as (1) addition of anti-let-7a 2′O-Me
oligonucleotide, but not a nonspecific anti-miR122 2′-O-Me oligonucleotide (Figure 1D, lanes
12 and 13, respectively), abrogated the deadenylation of 6xB-3′UTR RNA; and (2) the
6xBMUT-3′UTR RNA was not deadenylated (Figure 1D). A 6xB-3′UTR RNA with a longer
poly(A) tail (150 nt, 6xB-3′UTR*) behaved similarly to the 6xB-3′UTR RNA vis-a-vis the
time course and the deadenylation pattern (Figure 1E). Taken together, our findings
demonstrate that no RNA determinant other than the let-7 target sites is required for miRNA-
mediated deadenylation.
Argonaute Proteins Interact with CAF1 and CCR4 Deadenylases
We used several approaches to identify the deadenylase(s) involved in the miRNA-mediated
deadenylation. In one approach, Myc-tagged Ago1 and Ago2 were stably transfected into
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HEK293 cells. Tagged Ago proteins were immunopurified, and the associated proteins were
identified by using multidimensional protein identification technology (MuDPIT) (Washburn
et al., 2001; Wolters et al., 2001). This method was validated by the identification of known
Ago2-interacting proteins such as HSP90, DICER, TRBP, and GW182 (Figure 2A)
(Chendrimada et al., 2005; Landthaler et al., 2008; Liu et al., 2005; Meister et al., 2005). In
addition, PABP was identified in both Ago1 and Ago2 immunopurifications (Figure 2A) (Hock
et al., 2007; Landthaler et al., 2008). One identified protein that was not reported before to
interact with Ago proteins was CAF1 deadenylase. To validate this interaction, we performed
coimmunoprecipitation experiments using a micrococcal nuclease-treated Krebs extract. When
endogenous Ago2 was immunoprecipitated from the Krebs extract, the precipitated fraction
contained Ago2 and CAF1, but not eIF4E (Figure 2B). When endogenous CAF1 was
immunoprecipitated from Krebs extracts, the precipitated fraction contained CAF1, CCR4 (a
CAF1-associated deadenylase [Tucker et al., 2001]), and Ago2, but not eIF4E (Figure 2C).
To determine whether the CAF1 and CCR4 deadenylases can be recruited by the let-7-loaded
Ago2, we used a 2′-O-Me RNA target “bait” pulldown assay (Hutvagner et al., 2004).
Biotinylated 2′-O-Me oligonucleotides, which mimic partially complementary mRNA target
sites for let-7 or miR122 (a liver-specific miRNA [Lagos-Quintana et al., 2002] that can pull
down Ago2 from lysates derived from Huh7 liver cells [Figure S3]), were incubated in Krebs
extract and pulled down using streptavidin beads. The associated proteins were eluted and
analyzed by western blotting. Ago2 bound specifically to the anti-let-7 2′-O-Me beads and
failed to bind to control beads or anti-miR122 2′-O-Me beads (Figure 2D, lanes 2–4).
Importantly, in these pulldown experiments a similar pattern of enrichment was observed for
CAF1 and CCR4, but not for eIF4E or Tob (a protein that can associate with CAF1 to enhance
deadenylation [Ezzeddine et al., 2007; Mauxion et al., 2008]). These results demonstrate that
CAF1 and CCR4 can be specifically recruited to the target-bound let-7-loaded Ago2.
miRNAs Require CAF1 Activity to Promote Deadenylation
To determine whether CAF1 is required for miRNA-mediated deadenylation, it was
immunodepleted (~80%) from the Krebs extract using an affinity-purified CAF1 antibody
(Figure S4). Analysis of the depleted extract (Figure 3) demonstrated that miRNA-mediated
translation inhibition is partially relieved in both CAF1- and Ago2-depleted extracts (37.8%
[Figure 3B] and 14.9% repression [Figure 3D], respectively, after 3 hr incubation) when
compared to the corresponding control-depleted extracts (68.9% [Figure 3A] and 54.5%
[Figure 3C] repression after 3 hr incubation). The Ago2-depleted extract was dramatically
impaired in its ability to deadenylate the 6xB-3′UTR RNA, inasmuch as deadenylation was
barely detectable even after 6 hr of incubation (Figure 3E, lane 5). A similar decrease in
deadenylation was detected in a Krebs extract depleted of CAF1 (Figure 3F, lane 10). These
deadenylation defects were specific, because in a mock-depleted extract, 6xB-3′UTR RNA
was deadenylated in a let-7-dependent manner (Figures 3E and 3F, lanes 1–3). miRNA-
mediated deadenylation was modestly restored (2.2-fold increase; from ~5% to ~12%
deadenylation) by the addition of affinity-purified wild-type HA-CAF1 to the CAF1-depleted
extract (Figure 3F, lane 11), while wild-type HA-CAF1 had no noticeable effect on mock-
depleted extract (lane 4). Modest restoration was most likely due to a small fraction of affinity-
purified wild-type HA-CAF1 being bound to let-7-loaded miRISC. In contrast, addition of
affinity-purified catalytically inactive HA-CAF1 mutant (D40A) (Zheng et al., 2008)
decreased miRNA-induced deadenylation in both mock- and CAF1-depleted extracts (Figure
3F, lanes 5 and 12, respectively). This is likely due to HA-CAF1(D40A) acting as a dominant-
negative mutant in both mock- and CAF1-depleted extracts. Taken together, these results show
that miRNA-induced deadenylation is executed, at least in part, by the CAF1 deadenylase.
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Ago2-GW182 Interaction Is Essential for miRNA-Mediated Deadenylation
The Ago-binding protein GW182 is required for efficient miRNA-mediated silencing in C.
elegans and in Drosophila S2 cells (Behm-Ansmant et al., 2006; Ding and Han, 2007; Eulalio
et al., 2008b). GW182 is required for the assembly of P bodies, protein-RNA assemblies
thought to contribute to translation inhibition and mRNA destabilization (Behm-Ansmant et
al., 2006; Ding and Han, 2007; Jakymiw et al., 2007; Liu et al., 2005; Pillai et al., 2005;
Rehwinkel et al., 2005). CAF1 also localizes to P bodies in mammalian cells (Zheng et al.,
2008). We therefore investigated whether the GW182 interaction with Ago2 plays a role in
miRNA-mediated deadenylation in vitro. To this end, we used a 22 amino acid fragment of
GW182 (called “Ago hook”) (Figure 3G) that competes with GW182 for Ago binding and
inhibits miRNA-mediated repression in vivo (Till et al., 2007). A Krebs extract was incubated
with either GST alone, GST fused to Ago hook (GST-WT hook), or GST fused to a mutant
hook (GST-MUT hook) containing two Trp to Leu mutations that abrogate the ability of the
hook to bind to Ago (Till et al., 2007) (Figure S5). Addition of a recombinant GST-WT hook,
but not GST alone or GST-MUT hook to the Krebs extract, impaired the deadenylation of
6xB-3′UTR RNA in a concentration-dependent manner (Figure 3H, lanes 7–9 compared to
lanes 4–6 and 10–12, respectively). These findings indicate that miRNA-mediated
deadenylation in vitro requires GW182 contact with Ago2 at the hook site.
PABP Is Required for miRNA-Mediated Deadenylation
Since the MuDPIT analysis identified PABP as an Ago-interacting protein, it was pertinent to
determine whether PABP is necessary for miRNA-induced deadenylation. A Krebs extract was
depleted (>95%) of endogenous PABP using a GST-tagged PABP-interacting protein 2 (Paip2)
affinity matrix (Figure 4A). Paip2 is a strong translational inhibitor and acts by sequestering
PABP and blocking PABP-poly(A) tail and PABP-eIF4G interactions in vitro (Karim et al.,
2006; Khaleghpour et al., 2001). GST-Paip2 coupled to a resin was previously used to
efficiently deplete PABP from a Krebs extract, resulting in reduced translation (Kahvejian et
al., 2005). Strikingly, the PABP-depleted extract was severely impaired in its ability to
deadenylate the 6xB-3′UTR RNA (Figure 4B, compare lane 4 to lane 1). This was a specific
consequence of PABP depletion as a mock-depleted extract still deadenylated the reporter RNA
and was responsive to the addition of anti-let-7 2′-O-Me oligonucleotide (Figure 4B, lanes 1
and 2, respectively). Moreover, addition of recombinant GST-PABP (50% of endogenous
PABP levels in a Krebs extract [Figure S6]) to the PABP-depleted extract (lane 6), but not
GST alone (lane 5), completely rescued miRNA-mediated deadenylation of 6xB-3′UTR RNA.
The rescue was prevented by the addition of anti-let-7 2′-O-Me oligonucleotide (Figure S7,
lane 8). These findings clearly show that PABP is essential for miRNA-mediated deadenylation
in vitro.
PABP Function in miRNA-Mediated Deadenylation Is Antagonized by eIF4G
How does PABP facilitate miRNA-mediated deadenylation? PABP is probably not required
for miRISC target site recognition, as the let-7-loaded Ago2 can be pulled down with anti-let-7
2′-O-Me oligonucleotide from a PABP-depleted Krebs extract almost as well as from a
nondepleted extract (Figure 2D, compare lanes 3 and 7). Moreover, PABP is required for
recruiting neither CAF1 nor CCR4 as they are pulled down in similar amounts from PABP-
depleted extracts with anti-let-7 2′-O-Me oligonucleotide (Figure 2D, compare lanes 3 and 7).
It is unlikely that PABP’s role is to compete with other proteins for poly(A) tail binding, as
adding free poly(A) to PABP-depleted extracts (Figure S8) does not rescue miRNA-mediated
deadenylation.
The N-terminal region of PABP can interact with the translation initiation factor eIF4G, and
this interaction stimulates translation (Imataka et al., 1998; Wakiyama et al., 2000). To
determine whether this interaction might antagonize deadenylation, Krebs extract was
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incubated with increasing concentrations of either an N-terminal eIF4G fragment (GST-eIF4G
41-244wt) that binds the N terminus of PABP or a mutant eIF4G fragment (GST-eIF4G
41-244mut) that does not bind to PABP (Kahvejian et al., 2005) (Figures 5A and S9). Addition
of a wild-type (lanes 3–6), but not the mutant eIF4G fragment (lanes 7–10), impaired the
deadenylation of 6xB-3′UTR RNA in a concentration-dependent manner.
We next examined whether the effect of GST-eIF4G 41-244wt on miRNA-mediated
deadenylation was a result of its binding to PABP. PABP-depleted extracts were supplemented
with either wild-type or PABP M161A that cannot bind eIF4G (Groft and Burley, 2002)
(Figures 5B, 5C, and S9). miRNA-mediated deadenylation in PABP-depleted extracts can be
rescued equally well with PABP M161A as compared to wild-type PABP (Figure 5B, compare
lanes 5–7 with lanes 10–12). Addition of GST-eIF4G 41-244wt blocked deadenylation in a
PABP-depleted extract supplemented with wild-type PABP (lane 8) but decreased it only
minimally when supplemented with PABP M161A (lane 13). These findings suggest that the
eIF4G-PABP interaction is not required for, but rather interferes with, miRNA-mediated
deadenylation.
PABP Interacts with the C-Terminal Region of GW182
GW182 is a core component of miRISC, and its contact with Ago is required for miRNA-
mediated repression (Eulalio et al., 2008b; Till et al., 2007). Mammalian and C. elegans
GW182 protein orthologs were previously shown to coimmunoprecipitate with PABP
(Landthaler et al., 2008; Zhang et al., 2007), but whether these associations were direct has not
been determined. To test for a direct interaction between GW182 and PABP, we performed
GST pulldown experiments using recombinant His-tagged PABP and four GST- and FLAG-
tagged partially overlapping fragments (covering amino acids 1–500, 400–900, 800–1360, and
1260–1690) of the human GW182 protein TNRC6C (Figure 6A). GST on its own and fusions
with TNRC6C fragments 1–500, 400–900, and 800–1360 did not interact with PABP. In
contrast, the C-terminal 1260–1690 of TNRC6C, which harbors both the domain of unknown
function (DUF; Zipprich et al., 2009) and RRM domains of TNRC6C pulled down PABP very
efficiently (20% of input; Figure 6A). GST pulldown experiments using overlapping fragments
of another human GW182 paralog (TNRC6A) and PABP yielded similar results (data not
shown).
We next investigated whether the C-terminal region of TNRC6C interacts with PABP in
transfected HEK293 cells. Of the HA-tagged fragments spanning different regions of TNRC6C
(Figure 6B), only the C-terminal fragment, ΔN1370, encompassing residues 1370–1690, pulled
down endogenous PABP (Figure 6B, lane 8). In additional experiments, lysates from cells
expressing GST-ΔN1370 were used for GST pulldowns. In the absence of micrococcal
nuclease treatment, GST-ΔN1370 pulled down both PABP and eIF4G. However, in nuclease-
treated lysates GST-ΔN1370 pulled down only PABP (Figure 6C), demonstrating the RNA
independence of the interaction between TNRC6C and PABP. Taken together, these data
indicate that the C-terminal region of the GW182 protein TNRC6C interacts directly with
PABP in an RNA-independent manner.
GW182 Contact with the PABP C-Terminal Domain Is Required for Maximal miRNA-Mediated
Deadenylation
We next performed a sequence analysis of the C terminus of GW182 proteins to identify any
potential PABP-interacting motifs. We observed a short sequence within the DUF that shows
similarity to the Paip2 PAM2 motif (Figure 7A) that is required for Paip2 to bind the second
half of the PABP C terminus (C2) (Khaleghpour et al., 2001; Kozlov et al., 2004). GST
pulldown experiments were subsequently carried out using recombinant GST-tagged C-
terminal PABP fragments (GST-C1 and GST-C2) and the FLAG-tagged TNRC6C C terminus
Fabian et al. Page 6
Mol Cell. Author manuscript; available in PMC 2010 January 7.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
(covering amino acids 1260–1690 [Figure 7B]). The PABP GST-C1 fusion did not pull down
the GW182 1260–1690 fusion. In contrast, GST-C2 pulled down the TNRC6C C-terminal
fragment very efficiently (~40% of input).
To determine whether miRNA-mediated deadenylation requires GW182 contact with the
PABP C2 domain, a Paip2-derived PAM2 peptide that specifically binds the C2 domain (Figure
7C) was used. Addition of increasing concentrations of wild-type, but not mutant PAM2
peptide (F117A [Kozlov et al., 2004]) to GST-PABP incubated with TNRC6C 1260–1690
fragment, blocked, albeit not completely, the binding of the TNRC6C C terminus to PABP
(lanes 6–8 compared to lanes 9–11). Consistently, addition of the wild-type, but not the mutant
PAM2 peptide to a Krebs extract, interfered with miRNA-mediated deadenylation in vitro in
a dose-dependent manner (Figure 7D, lanes 3–6 compared to lanes 7–10). Taken together,
these findings demonstrate that maximal miRNA-mediated deadenylation in vitro requires
GW182 contact with the PABP C2 domain.
To further assess the function of the GW182 C terminus in miRNA-mediated deadenylation,
we added the C-terminal recombinant 1260–1690 fragment to in vitro deadenylation reactions.
The fragment dramatically enhanced miRNA-mediated deadenylation in vitro (Figure 7E,
lanes 7–10 as compared to lane 2). The enhancement is specific, since adding a TNRC6C
fragment 800–1360 that overlaps the 1260–1690 fragment but cannot bind PABP inhibited
rather than enhanced the deadenylation in the same assays (lanes 11–14 as compared to lane
2). These data demonstrate the key role that the PABP-GW182 interaction plays in miRNA-
mediated deadenylation.
DISCUSSION
In this report we used a mammalian cell-free extract to demonstrate that miRNAs mediate
deadenylation of a target mRNA subsequent to initial inhibition of cap-dependent translation.
Biochemical methods and functional assays in this in vitro system elucidated some of the
protein and RNA requirements for miRNA-mediated mRNA deadenylation.
CAF1 and CCR4 Are Mammalian miRISC-Associated Deadenylases
miRNAs have previously been implicated in the deadenylation of targeted mRNAs in
mammalian cells (Wu et al., 2006). One major deadenylase complex in mammals is the
multisubunit CCR4-NOT complex, which contains two proteins having deadenylase activity,
CCR4 and CAF1 (Yamashita et al., 2005; Zheng et al., 2008). Although CCR4 is the active
deadenylase in the yeast CCR4-NOT complex (Tucker et al., 2001, 2002), mammalian CAF1
is also a processive deadenylase that regulates mRNA decay (Bianchin et al., 2005; Funakoshi
et al., 2007; Schwede et al., 2008; Viswanathan et al., 2004; Zheng et al., 2008). Previous work
carried out in Drosophila S2 cells demonstrated that the CCR4-NOT complex (which contains
CAF1) facilitates miRNA-mediated deadenylation (Behm-Ansmant et al., 2006). Our results
bolster these findings and show that the association of the miRISC with the deadenylase
complex is conserved between Drosophila and mammals. Moreover, we provide biochemical
evidence that both deadenylases physically interact with the mammalian miRISC, and that
CAF1 activity is responsible, at least in part, for miRNA-mediated deadenylation. As CAF1
interacts with both Ago1 and Ago2 in HEK293 cells, this suggests that both Ago proteins are
involved in facilitating miRNA-mediated deadenylation in mammals.
PABP as a Coactivator of miRNA-Mediated Deadenylation
Studies aimed at characterizing miRISC-associated proteins have previously identified PABP
by mass spectrometry of immunoprecipitates not subjected to ribonuclease treatment (Hock et
al., 2007; Landthaler et al., 2008; Zhang et al., 2007). We show that PABP is required for
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miRNA-mediated deadenylation and physically interacts with the miRISC via direct contact
with GW182. Moreover, our results suggest that PABP-GW182 interaction is required to
facilitate miRNA-mediated deadenylation. Previous studies have shown that PABP augments
the activity of different deadenylases. PABP helps to recruit the PAN2/3 deadenylase complex
to poly(A) tails in both yeast and mammalian systems via a direct interaction between the PAN3
subunit and the PABP C-terminal domain (Lowell et al., 1992; Uchida et al., 2004). The PABP
C-terminal domain directly binds to the CAF1-interacting protein Tob, which may contribute
to the CCR4-CAF1-mediated deadenylation of some mRNAs (Ezzeddine et al., 2007; Simon
and Seraphin, 2007). In contrast to these modes of PABP-dependent deadenylation, our data
show that PABP is not required for recruitment of either the miRISC or the miRISC-associated
deadenylase complex to miRNA-targeted mRNAs (Figure 2D). Furthermore, while CAF1 is
recruited to the miRISC, Tob is not Figure 2D).
PABP-GW182 Interaction and miRNA-Mediated Repression
GW182 is a core component of the miRISC and is critical for miRNA-mediated repression.
All three mammalian paralogs of GW182 (TNRC6A, TNRC6B, and TNRC6C) are involved
in miRNA-mediated repression (Jakymiw et al., 2007; Lazzaretti al., 2009; Liu et al., 2005;
Till et al., 2007; Zipprich et al., 2009). Tethering experiments of different TNRC6C fragments
to a reporter mRNA demonstrated that a C-terminal fragment of TNRC6C, harboring both the
DUF and RRM domains, represses protein synthesis as effectively (>10-fold) as a full-length
TNRC6C protein (Zipprich et al., 2009). Experiments performed with Drosophila GW182
protein in S2 cells also pointed to the importance of the protein C terminus for repression of
protein synthesis (Chekulaeva et al., 2009; Eulalio et al., 2009b), implying functional
conservation. We demonstrate that the mammalian GW182 C terminus directly binds PABP
in an RNA-independent manner. Importantly, we show that GW182-PABP contact through
the PABP C2 domain is required for efficient miRNA-mediated deadenylation. Because PABP
functions as a bona fide translation initiation factor (Kahvejian et al., 2005), these data provide
evidence that the mammalian miRISC directly interacts with a component of the translation
initiation machinery. It is possible that PABP binding to GW182 may compete with eIF4G
binding, as adding an eIF4G fragment that binds to the N terminus of PABP blocks miRNA-
mediated deadenylation in vitro (Figure 5). In addition, it is conceivable that PABP binding to
GW182 may function to juxtapose the poly(A) tail against the miRISC-associated deadenylase
complex (see model, Figure 8). Although intriguing, these possibilities are still speculative at
this point and await future experimental validation.
Temporal Mode of miRNA Action
miRNAs inhibit translation and/or mediate deadenylation and decay of target mRNAs
(Filipowicz et al., 2008). In previous studies, mostly carried out in cultured cells, it was
impossible to determine the earliest events leading to the miRNA-mediated repression (Behm-
Ansmant et al., 2006; Giraldez et al., 2006; Humphreys et al., 2005; Petersen et al., 2006; Pillai
et al., 2005). We have demonstrated that miRNAs inhibit translation initiation as early as 15–
40 min after addition of mRNA to the Krebs extract (Mathonnet et al., 2007, and this study).
As shown in this work, the miRNA-induced deadenylation of targeted mRNAs in vitro is a
slower event, which follows the miRISC-mediated repression of translation initiation. These
results indicate that miRNAs can function by two complementary and likely sequential
mechanisms, first by inhibiting initiation of cap-dependent translation, which is then followed
by the deadenylation of the target mRNA. As miRNA-mediated repression in Krebs extract
further increases between 1 and 2 hr of incubation and miRNA-mediated translation repression
is partially inhibited in CAF1-depleted extract, it is possible that deadenylation has an
additional repressive effect supplementary to the initial inhibition of cap-dependent translation.
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EXPERIMENTAL PROCEDURES
DNA Constructs and Protein Purification
Myc-Ago1 and Ago2 DNA constructs have been described (Liu et al., 2005). HA-CAF1 wild-
type and HA-CAF1 D40A constructs have been described (Zheng et al., 2008). pGST-Paip2
and pGST-PABP full-length and fragments C1 and C2 have been described (Khaleghpour et
al., 2001). Plasmids encoding wild-type and mutant HA-fused CAF1 proteins were transfected
into HeLa cells and proteins were eluted with HA peptide (Anaspec). Eluted proteins were
analyzed by western blot analysis using CAF1 and Ago2 antibodies. The plasmids pCI-
NHA-1-405, pCI-NHA-1-1034, pCI-NHA-1-1368, pCI-NHA-ΔN1370, and pCI-
NHA-1505-1610 were previously described (Zipprich et al., 2009). To generate the plasmid
pEBG-ΔN1370, the sequence encoding a C-terminal part of TNRC6C was PCR amplified
using CCCGTCG GATCCCGTGCCAAATCTGACAG TGA and
AACCCTCACTAAAGGGAAGC oligonucleotides as primers and pCI-NHA-ΔN1370 as
template. The fragment was digested with BamHI and NotI and inserted into pEBG-Piwi
(Tahbaz et al., 2004; Zipprich et al., 2009) precut with BamHI and NotI.
To generate the plasmids used for bacterial expression of GST-FLAG-TNRC6C fragments
(pGST-TNRC6C1-500, pGST-TNRC6C400-900, pGST-TNRC6C800-1360, and pGST-
TNRC6C1260-1690), the appropriate DNA was amplified by PCR using pCI-NHA-TNRC6C
as template and the following primer pairs: GGCCGGCCGTCGACTCATGGC
TACAGGGAGTGCCCAGGG CAAC and CTTGTCATCGTCGTCCTTGTAGTCAGCA
CTGTTCATGATGGAC CCATCGTTCTTC (1–500), GGCCGGCCGTCGACTCAGTG
ATGGTTCTGGC AACCACAATGAAG and CTTGTCATCGTCGTCCTTGTAGTCAG
CCACGTC CCCTTCTTCATCCTCCCACTG (400–900), GGCCGGCCGTCGACTCTC
ATC AGGCTGGGGAGAAATGCCTAATG and CTTGTCATCGTCGTCCTTGTAGTC
AGCGGGAGGACTGGCTGGTGACTCACTGTTC (800–1360), and GGCCGGC CGTC
GACTCAACACCTTTGCTCCTTACCCTCTCGCTG and CTTGTCATCG TCGTCCTT
GTAGTCAGCCAGGGACTCCCCGCTGAGCAGGTCCCC (1260–1690). These PCR
products were subjected to a second round of PCR amplification using the original forward
primer and a new reverse primer (CCGGC CGCGGCCGCTCACTTGTCATCGT
CGTCCTTGTAGTCAGC). The product of these PCR reactions was then gel purified, digested
with SalI and NotI restriction enzymes, and ligated into similarly digested pGEX-6P-1
expression vector (GE Healthcare). This strategy resulted in constructs that express the
appropriate fragment of TNRC6C carrying N-terminal GST and C-terminal FLAG epitopes.
TNRC6C fragments were expressed in Rosetta-2(DE3) E. coli cells (EMD Biosciences) and
purified by two sequential affinity chromatography steps, first over glutathione Sepharose 4B
resin (GE), followed by M2-FLAG affinity resin (Sigma).
In Vitro Transcription
Plasmids that lack or contain six let-7 target sites (RL and RL-6xB, respectively) were
described (Pillai et al., 2005). A 98 base pair poly(A) sequence was added to the 3′UTR of both
constructs. RL-6xBMut was constructed as previously published (Mathonnet et al., 2007; Pillai
et al., 2005). A 150 base pair poly(A) sequence was synthesized (IDT) and added to the 3′UTR
of RL-6xB (RL-6xB-pA*). For in vitro transcription, plasmids were linearized with ApaI and
filled in using the Klenow fragment. Transcription reactions were performed using MAXIscript
In Vitro Transcription Kit (Ambion) in 20 μl at 37°C according to the manufacturer’s protocol
in the presence of the cap analog m7(3′-O-methyl)(5′)Gppp(5′)G (anti-reverse cap analog,
ARCA; New England Biolabs). ApppG-capped mRNAs were synthesized using ApppG (New
England Biolabs) instead of ARCA. 6xB-3′UTR and 6xBMUT-3′UTR transcripts were
generated from PCR products derived from RL-6xB-pA and RL-6xBMUT-pA templates and
T7-3′UTR
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(GGCGCCTAATACGACTCACTATAGGGGTAAGTACATCAAGAGCTTCG) and Oligo
3R(−) (GGTGACACTATAGAATAGGGCCC) primers. PCR products were digested with
ApaI and filled in using the Klenow fragment. To synthesize radiolabeled mRNAs, UTP was
substituted with [α-32P]UTP (800 Ci/mmol, 10 mCi/ml; PerkinElmer) according to the
manufacturer’s protocol. The mRNA was loaded on a mini Quick Spin RNA Column (Roche)
to remove unincorporated nucleotides.
In Vitro Translation Assays
Krebs-2 ascites cell extract was prepared as previously described (Svitkin and Sonenberg,
2004). Translation reactions were performed in a total volume of 10 μl at 30°C. A typical
reaction mixture contained 7 μl extract, 1 μl mRNA, and, where indicated, 2′-O-Me
oligonucleotide complementary to let-7a or miR-122a or poly(A)30 oligonucleotide
(Dharmacon) in water. The mixture was preincubated for 20 min at 16°C and then at 30°C for
120 min. When the 2′-O-Me oligonucleotide was added, the extract was first incubated at 30°
C for 20 min in the absence of mRNA to allow for the annealing of the oligonucleotide with
its target miRNA. The reaction was stopped by addition of 20 μl cold 1 × PBS. For time course
experiments, the reaction was scaled up to 80 μl, and 10 μl was withdrawn at each time point.
Luciferase activity was measured by using the Dual-Luciferase Reporter Assay System
(Promega) according to the manufacturer’s protocol.
mRNA Stability Assay
Radiolabeled RNA (0.1 ng) was incubated in Krebs-2 ascites in a total volume of 10 μl in the
absence or presence of 10 nM let-7 2′-O-Me oligonucleotide. Aliquots of the reaction mixture
were withdrawn at specific intervals, and the RNA was extracted using TRIzol reagent
(Invitrogen) and loaded on a 4% or 4.5% polyacrylamide/urea gel. The gel was dried and
analyzed using a Typhoon PhosphorImager (GE Healthcare).
Oligonucleotide Ligation-Mediated Cloning of RNA
Radiolabeled RNA from Krebs extract was extracted with TRIzol and loaded on a 4%
polyacrylamide/urea gel. Specific RNA bands were cut from the gel and eluted in 2× proteinase
K buffer (100 mM Tris-HCl, pH 8.3; 25 mM EDTA, pH 8.0; 300 mM NaCl; 2% (w/v) SDS),
purified and ligated to a miRNA universal linker (NEB) using T4 RNA ligase 1 in the absence
of ATP. Ligation products were purified and reverse transcribed with Superscipt III
(Invitrogen), and amplified using Titanium DNA polymerase (Clontech). PCR products were
cloned and sequenced.
Immunodepletion Assay, GST Pulldown Assay, Western Blotting, and Antibodies
protein G-Sepharose (GE Healthcare) (20 μl) was washed and incubated in 100 μl of Krebs
extract with 6 μg of either mouse monoclonal anti-HA (Covance), rabbit anti-HA (Sigma),
mouse monoclonal anti-Ago2 (Wako Chemicals), or affinity-purified rabbit polyclonal anti-
CAF1 with gentle agitation for 2 hr at 4°C. The resin was then centrifuged at 500 × g, and the
supernatant was collected. GST pulldown assays of Krebs extract have been described
(Kahvejian et al., 2005). Antibodies and their working dilutions for western blotting were as
follows: rabbit polyclonal anti-Ago2, 1:1000; rabbit polyclonal anti-PABP, 1:1000 (Cell
Signaling Technologies); mouse monoclonal anti-Actin, 1:5000 (Sigma); mouse monoclonal
anti-FLAG, 1:5000 (Sigma); mouse monoclonal anti-CAF1, 1:1000; mouse monoclonal anti-
Tob 4B1, 1:1000 (Sigma); and mouse monoclonal anti-CCR4, 1:1000. For the GST pulldown
assay with HEK293 cell extracts, cells were lysed with 50 mM Tris-HCl (pH 7.5) containing
150 mM KCl, 0.5% Triton X-100, 2 mM DTT, and complete EDTA-free protease inhibitor
cocktail (Roche). The cleared lysate was incubated with glutathione Sepharose 4B (GE
Healthcare) followed by washing with 50 mM Tris-HCl (pH 7.5), containing 150 mM KCl,
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0.1% Triton X-100, 2 mM DTT, and complete protease inhibitor cocktail (Roche). Proteins
associated with glutathione Sepharose beads were eluted with 50 mM glutathione in the same
buffer as used for washing the beads and analyzed by western blotting using anti-PABP1
antibody (Cell Signaling Technology), anti-eIF4GI antibody (Gradi et al., 1998), and anti-GST
antibody (GE Healthcare). To examine RNA dependence of protein-protein interactions,
cleared lysates were treated with micrococcal nuclease (Roche) (10 μg/ml) for 25 min at room
temperature in the presence of 1 mM CaCl2 before incubation with glutathione Sepharose 4B
beads.
Anti-let-7 2′-O-Me Oligonucleotide Biotin Pulldown Assay
M-280 streptavidin magnetic Dynabeads (Invitrogen) were washed three times in buffer D (25
mM HEPES-KOH [pH 7.3], 2 mM MgCl2, 50 mM KCl, 75 mM KOAc) and resuspended in
buffer D with 2 mM DTT and 1 M NaCl and incubated with biotin-labeled anti-let-7 2′-O-Me,
anti-miR122 2′-O-Me, or anti-miR35 2′-O-Me oligonucleotide (Integrated DNA
Technologies) for 60 min at 4°C. 2′-O-Me-bound beads were washed three times in buffer D
and then incubated in aliquots of Krebs extract containing protease inhibitors at 30°C for 60
min. Beads were washed three times in buffer D with 0.5% NP-40 and boiled in SDS sample
buffer and analyzed by SDS-PAGE and western blotting.
Cell Lines
HEK293 cells were transfected with Myc-Ago1 and Myc-Ago2 DNA constructs using LT-1
transfection reagent according to the manufacturer’s instructions (Mirus). All constructs
contain a G418 resistance cassette. Stable transfectants were selected with 500 μg/ml G418
(Roche) for at least 2 weeks prior to being used in experiments.
Other HEK293T cells were grown in Dulbecco’s modified Eagle’s medium (DMEM; GIBCO-
BRL) supplemented with 2 mM L-glutamine and 10% heat-inactivated fetal calf serum (FCS).
Transfections were performed in 10 cm cell culture dishes with ~60% confluent cells using
Nanofectin (PAA Laboratories), following the manufacturer’s instructions. For mass
spectrometry analysis, cells in one 10 cm cell culture dish were transfected with 6 μg of the
plasmid pEBG-DN1370. For IP experiments, cells in 10 cm cell culture dishes were transfected
with 6 μg of the plasmids pCI-NHA-1505-1610 and pCI-NHA-ΔN1370 and 20 μg of the
plasmids pCI-NHA-1-405, pCI-NHA-1-1034, and pCI-NHA-1-1368. For the GST pulldown
experiment cells, 10 cm cell culture dishes were transfected with 4 μg of the plasmid pEBG-
ΔN1370.
Mass Spectrometry Analysis
Cells were lysed with 50 mM Tris-HCl (pH 7.5) containing 150 mM KCl, 5 mM MgCl2, 1
mM CaCl2, 0.5% Triton X-100, 2 mM DTT, and EDTA-free protease inhibitor cocktail
(Roche). The cleared lysate was incubated with glutathione Sepharose 4B (GE Healthcare)
followed by washing with 50 mM Tris-HCl (pH 7.5) containing 150 mM KCl, 5 mM MgCl2,
1 mM CaCl2, 0.5% Triton X-100, 2 mM DTT, and EDTA-free protease inhibitor cocktail
(Roche). Cysteine residues of proteins associated with the beads were reduced and alkylated
prior to gel separation. The Coomassie-stained bands were digested with trypsin, and tryptic
peptides were analyzed by nano-HPLC (Agilent 1100 nanoLC system, Agilent Technologies,
Santa Clara, CA) coupled to a 4000 Q TRAP mass spectrometer (Applied Biosystems, Foster
City, CA). Peptides were identified searching UniProt database (version 13.8) restricted to
human using Mascot (version 2.1, Matrix Science, London).
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MuDPIT and Coimmunoprecipitation Analysis
Samples were prepared as follows: HEK293 cells were harvested and washed with phosphate-
buffered saline (PBS). Cells were washed once in hypotonic lysis buffer (10 mM Tris-HCl [pH
7.5], 10 mM KCl, 1.5 mM MgCl2, 5 mM DTT, and EDTA-free protease inhibitor cocktail
[Roche]) and allowed to swell for 20 min on ice prior to homogenization. Cell extracts were
centrifuged in a tabletop centrifuge at 10,000 rpm for 30 min at 4°C to clarify the lysate. The
salt concentration in the extract was raised to 100 mM KCl. To immuno-precipitate Ago and
Ago-interacting proteins, Myc-agarose beads (Sigma) were added to the extract and allowed
to incubate for 6 hr with gentle rotation. Immunoprecipitates were washed (wash buffer, 10
mM Tris-HCl [pH 7.5], 100 mM KCl, 1.5 mM MgCl2, 5 mM DTT, and EDTA-free protease
inhibitor cocktail [Roche]) four times for 30 min each. Immunocomplexes were eluted from
Myc-agarose beads by two serial washes in elution buffer (100 mM Tris-HCl [pH 8.0], 8M
urea). Proteins in eluates were precipitated with trichloroacetic acid and submitted for MuDPIT
analysis (Washburn et al., 2001). Samples analyzed for coimmunoprecipitation of Ago and
Ago-interacting proteins from HEK293 cells were prepared as above. In cases in which
immunoprecipitates were subjected to RNase A treatment, immunoprecipitation was
performed as described, but the next to last washing step was done in the presence of RNase
A (10 units/ml in wash buffer). Samples were washed an additional two times prior to SDS-
PAGE and western blot analysis. Samples analyzed for coimmunoprecipitation of Ago2- and
CAF1-interacting proteins from Krebs extracts were prepared as follows: Krebs extracts were
treated with micrococcal nuclease (Roche) in the presence of CaCl2 for 30 min at 20°C and
subsequently with EGTA as previously described (Svitkin and Sonenberg, 2004). Krebs
extracts were then mixed with protein G Dynabeads (Invitrogen) already bound to either mouse
monoclonal anti-HA (Covance), rabbit anti-HA (Sigma), mouse monoclonal anti-Ago2 (Wako
Chemicals), or affinity-purified rabbit anti-CAF1 and gently mixed at 30°C for 60 min.
Immunoprecipitates were washed five times with buffer D containing 0.5% NP-40 prior to
SDS-PAGE and western blot analysis. For HA epitope IP reactions, cells were lysed with 50
mM Tris-HCl (pH 7.5) containing 150 mM KCl, 0.5% Triton X-100, 2 mM DTT, and protease
inhibitor cocktail (Roche). The cleared lysate was incubated with Anti-HA Affinity Matrix
(Roche). After washing with 10 mM Tris-HCl (pH 7.5) containing 200 mM KCl, proteins
associated with the beads were analyzed by western blotting using anti-HA 3F10 antibody
(Roche) and PABP1 antibody (Cell Signaling Technology) (Polacek et al., 2009).
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Figure 1. Deadenylation Mediated by let-7 miRNA in a Krebs Extract
(A) Schematic representation of the Renilla luciferase (Rluc) reporter mRNAs. Sequences of
the let-7-binding sites (RL-6xB) and mutated seed sites (RL-6xBMut) are shown below the
drawings.
(B) Time course of RL-6xB-pA and RL-6xBMUT-pA mRNA deadenylation as determined by
autoradiography. Reporter mRNAs were incubated in the presence or absence of 10 μM
cycloheximide, 1 mM hippuristanol, or 10 nM 2′-O-Me oligonucleotide (either anti-let-7a or
anti-miR122).
(C) A time course of translation of RL-pA, RL-6xB-pA, and RL-6xB-pA in the presence of
anti-let-7 2′-O-Me. Average percentage repression is labeled below each time point. Error bars
represent the standard deviation of three independent experiments.
(D) Schematic representation of the 6xB-3′UTR reporter RNA and time course of 6xB-3′UTR
and 6xBMUT-3′UTR RNA deadenylation in a Krebs extract as determined by
autoradiography. Reporters were incubated in the presence or absence of 10 nM 2′-O-Me
oligonucleotide (either anti-let-7a or anti-miR122), and their stability was monitored by
autoradiography.
(E) Schematic representation of the 6xB-3′UTR reporter RNAs with either 98As or 150As (*).
Time course of 6xB-3′UTR and 6xB-3′UTR* deadenylation in a Krebs extract as determined
by autoradiography. Polyadenylated and deadenylated mRNAs are marked on the right of the
figure.
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Figure 2. Ago Proteins Interact with PABP and the CAF1/CCR4 Deadenylase Complex
(A) MuDPIT analysis of Ago1- and Ago2-interacting proteins. Identified proteins are listed
along with corresponding peptide coverage for Ago1 and Ago2 coimmunoprecipitations.
(B) Immunoprecipitation of endogenous Ago2 protein from micrococcal nuclease-treated
Krebs extract using anti-Ago2 antibody. Immunoprecipitated complexes were subjected to
SDS-PAGE and probed with anti-Ago2 antibody, anti-CAF1 antibody, anti-PABP antibody,
or anti-eIF4E antibody.
(C) Immunoprecipitation of endogenous CAF1 protein from micrococcal nuclease-treated
Krebs extract using anti-CAF1 antibody. Immunoprecipitated complexes were subjected to
SDS-PAGE and probed with anti-Ago2 antibody, anti-CAF1 antibody, anti-CCR4 antibody,
or anti-eIF4E antibody.
(D) Pulldown of Ago2, CCR4, and CAF1 from micrococcal nuclease-treated Krebs extracts
using biotin-conjugated anti-let-7 2′-O-Me oligo-nucleotide and streptavidin Dynabeads.
Isolated complexes were subjected to SDS-PAGE and probed with anti-Ago2 antibody, anti-
CAF1 antibody, anti-CCR4 antibody, anti-Tob antibody, or anti-eIF4E antibody.
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Figure 3. let-7-Mediated Deadenylation Requires CAF1, Ago2, and GW182
(A–D) Time course of RL-pA and RL-6xB-pA translation in rabbit anti-HA- (A), rabbit anti-
CAF1- (B), mouse anti-HA- (C), and mouse anti-Ago2-depleted Krebs extracts (D). Average
percentage repression is labeled below each time point. Error bars represent the standard
deviation of three independent experiments.
(E) 6xB-3′UTR RNA deadenylation in the presence or absence of 10 nM anti-let-7a 2′-O-Me
in control (mouse anti-HA) or anti-Ago2-depleted Krebs extract. 6xB-3′UTR RNA
deadenylation was followed by autoradiography. Polyadenylated and deadenylated mRNAs
are marked on the right of the figure.
Fabian et al. Page 19
Mol Cell. Author manuscript; available in PMC 2010 January 7.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
(F) 6xB-3′UTR RNA deadenylation in control (rabbit anti-HA) or anti-CAF1-depleted extract
in the presence or absence of either 10 nM anti-let-7a 2′-O-Me oligonucleotide, or WT or D40A
HA-CAF1 protein.
(G) Wild-type and mutant hook peptides derived from GW182.
(H) 6xB-3′UTR RNA deadenylation in Krebs extract in the presence or absence of either GST
or GST hook peptides at concentrations ranging from 0.1 to 2.0 μg per reaction, respectively.
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Figure 4. let-7-Dependent Deadenylation Requires PABP
(A) Western blot analysis of Krebs-2 extracts depleted with either GST (Control Extract) or
GST-Paip2 (PABP-depleted Extract) probed with anti-PABP antibody and anti-β-actin
antibody.
(B) A-capped 6xB-3′UTR RNA incubated in either mock-depleted (lanes 1–2) or PABP-
depleted extract (lanes 3–6). PABP-depleted extract was supplemented with recombinant GST,
GST-PABP (100 ng, which is the equivalent of roughly 50% of endogenous PABP present in
an in vitro reaction), and RNA stability was monitored by autoradiography. Polyadenylated
and deadenylated mRNAs are marked on the right of the panel.
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Figure 5. eIF4G Contact with PABP Antagonizes miRNA-Mediated Deadenylation
(A) 6xB-3′UTR RNA deadenylation in Krebs extract in the presence or absence of increasing
concentrations (0.15, 0.5, 1.0, and 3.0 μg per reaction) of wild-type or mutant GST-eIF4G
41-244.
(B) 6xB-3′UTR RNA deadenylation in mock- or PABP-depleted Krebs extract in the presence
or absence of increasing concentrations (25, 50, or 100 ng per reaction, respectively) of either
wild-type (lanes 5–7) or M161A PABP (lanes 10–12) and/or wild-type (lanes 8 and 13) or
mutant (lanes 9 and 14) GST-eIF4G (41-244).
(C) Quantification of deadenylated bands as a percentage of total RNA in (B) is shown in bar
graphs (with standard deviations).
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Figure 6. The C Terminus of TNRC6C Directly Binds PABP
(A) Schematic representation of human TNRC6C and GST- and FLAG-tagged recombinant
protein fragments. Western blot analysis of GST pull-downs of PABP incubated with GST or
various fragments of GST-TNRC6C-FLAG and probed with anti-PABP and anti-GST
antibodies.
(B) Schematic representation of human TNRC6C HA-tagged fragments transfected into
HEK293 cells. Cell extracts of HEK293 cells, transiently expressing the indicated fusion
proteins, were incubated with Anti-HA Affinity Matrix (Roche), and immunoprecipitated
proteins were analyzed by western blotting using the indicated antibodies. Inputs represent 1%
of the cell extract used for IP. Nontransfected cells served as a control.
(C) Cell extracts of HEK293 cells transiently expressing GST-ΔN1370 were pulled down using
glutathione Sepharose resin in the presence or absence of micrococcal nuclease. GST
pulldowns were analyzed by western blotting using anti-PABP, anti-eIF4G, and anti-GST
antibodies. Non-transfected cells served as a control.
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Figure 7. GW182 Binding to PABP Is Required for miRNA-Mediated Deadenylation
(A) Alignment of GW182 DUF sequences with Paip2 PAM2 motif.
(B) Western blot analysis of GST pulldowns of TNRC6C (1260-1690)-FLAG incubated with
various C-terminal (C1 and C2) fragments of GST-PABP and probed with anti-FLAG and
anti-GST antibodies.
(C) Western blot analysis of GST pulldowns of GST-PABP incubated with TNRC6C
(1260-1690)-FLAG and/or wild-type or mutant PAM2 peptide and probed with anti-FLAG
and anti-GST antibodies.
(D) 6xB-3′UTR RNA deadenylation in Krebs extract in the presence of increasing
concentrations (1, 10, 50, and 100 μM) of wild-type or mutant (F > A) Paip2 PAM2 peptides.
(E) 6xB-3′UTR RNA deadenylation in Krebs extract, as determined by autoradiography, in
the presence of increasing concentrations (0.5, 1.0, and 2.0 μg per reaction) of GST, TNRC6C
(1260-1690), or TNRC6C (800-1360).
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Figure 8. Model for Temporal Stepwise miRNA-Mediated Gene Silencing
(i) mRNA circularization via eIF4G-PABP interaction stimulates cap-dependent translation
by enhancing eIF4E’s binding to the mRNA 5′ cap structure (strong binding [Kahvejian et al.,
2005]).
(ii) miRISC binds to its target site in the 3′UTR. GW182 binds to PABP, hypothetically
inhibiting its interaction with eIF4G, thereby repressing cap-dependent translation by
decreasing eIF4E’s binding to the 5′ cap structure (weaker binding), and sequestering the poly
(A) tail into the vicinity of CAF1 and CCR4 deadenylases (illustrated by an arrow) to facilitate
deadenylation of the mRNA. The interaction between CAF1/CCR4 and Ago2 is probably
indirect through other proteins (depicted as question marks).
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